Octozi raises $3M in seed funding, led by Surface Ventures, to enhance clinical development with Agentic AI solutions.
Amount Raised
$3 Million
Round Type
Seed
New YorkBiotechnologySoftwareHealth CareArtificial IntelligenceInvestors
Description
Octozi, an AI company that automates clinical development workflows, has secured $3 million in seed funding. The funding round was led by Surface Ventures, with additional participation from Remarkable Ventures. Octozi's platform aims to streamline data processes in clinical trials and improve efficiency. The funding will help advance their AI-driven solutions in the pharmaceutical sector.
Who to call at Octozi, and when
A new round usually means Octozi is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Octozi raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Octozi, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Octozi. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Octozi raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Octozi raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.